Slynd 4 MG tablet UU 28S
Ended Awarded
- Contract number
- SPE2DR26F8ZY8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,849
Award facts
- Contract value 100% obligated
- $10,849.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,849.14 to AmerisourceBergen Drug Corp for SLYND 4 mg tablets (28-count unit doses) with a firm fixed price contract type. This non-set-aside award was issued on November 3, 2025, with an ultimate completion date of November 4, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999 comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply diverse pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. All of AmerisourceBergen's reviewed contract awards have been competitively awarded and non-set-aside, reflecting its competitive standing in federal procurement. The DLA plans to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards involving several contractors, positioning AmerisourceBergen to continue serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract vehicles.
Quick answers
Who was awarded contract SPE2DR26F8ZY8?
SPE2DR26F8ZY8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DR26F8ZY8 worth?
The government has obligated $10,849 on SPE2DR26F8ZY8.
Is contract SPE2DR26F8ZY8 an order under another contract?
Yes. SPE2DR26F8ZY8 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F8ZY8 competed?
The extent of competition for SPE2DR26F8ZY8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award